64 results on '"G. Basile"'
Search Results
2. Chemotherapy vs. immunotherapy as neoadjuvant therapies in cisplatin-eligible patients undergoing radical cystectomy for muscle invasive bladder cancer
3. Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience
4. Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression
5. Functional outcomes prediction after robotic partial nephrectomy using PADUA score assessed with 3D virtual models: Preliminary results of a collaborative ERUS study
6. Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer?
7. Is it possible a surveillance deintensification in high-grade non-muscle invasive bladder carcinoma treated with bacillus Calmette-Guérin? A multiple survival approach for recurrence and progression risk dynamics
8. Machine learning-based survival model optimizes the outcome prediction in high-grade T1 bladder carcinoma: Improving selection of suitable candidates for timely radical cystectomy
9. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma
10. Impact of neoadjuvant immune-checkpoint inhibitor on intra and post operative outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy
11. Frailty Index in predicting surgical outcomes after partial nephrectomy in patients with renal cell carcinoma
12. The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database
13. 3D virtual models improve the accuracy of nephrometric scores in predicting surgical complexity during robotic partial nephrectomy: Results of a collaborative ERUS validation study
14. Development of a nomogram to predict benign pathology in a large series of minimally invasive partial nephrectomy
15. Do all patients equally benefit from the Enhanced Recovery After Surgery (ERAS) protocol after radical cystectomy?
16. Impact of pT-stage at second transurethral resection on recurrence and progression risk dynamics in a contemporary series of high-grade T1 bladder carcinoma treated with adequate bacillus Calmette-Guérin: Implications for management
17. Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma
18. Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery
19. Diagnostic performance of PET-CT compared to conventional CT for lymph node staging in bladder cancer patients undergoing radical cystectomy and bilateral pelvic lymph node dissection
20. The implementation of systematic biopsies in the endoscopic management of upper tract urothelial cancer
21. Second-look ureteroscopy scheduling for upper tract urothelial carcinoma: Do we need to rush?
22. The optimal management after ventral onlay buccal mucosa graft urethroplasty failure
23. Non-absorbable clip migration after robot-assisted partial nephrectomy: A rare but challenging complication
24. Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study
25. Ex vivo assessment of surgical margins with confocal laser microscopy during minimally-invasive radical prostatectomy: Our first 50 cases
26. Initial experience of robot-assisted partial nephrectomy with Hugo RAS™ system: Implications for surgical setting
27. Venous tumour thrombus in renal cell carcinoma: Locally advanced or metastatic disease?
28. The black box of intraoperative adverse incident reporting during radical cystectomy: Not only post-operative complications matter
29. Ex vivo confocal microscopy to diagnose upper tract urothelial carcinoma during URS
30. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer
31. A new machine learning model to predict Novel Trifecta achievement and validation of its prognostic significance in a large single centre series of minimally invasive partial nephrectomy
32. Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort
33. Oncologic surveillance for variant histology upper tract urothelial carcinoma
34. Prediction of 90-day mortality after radical cystectomy for bladder cancer in large-scale multicenter collaboration study
35. Pancreatic metastases after surgery for renal cell carcinoma
36. When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma
37. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma
38. Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery
39. Risks and benefits of partial nephrectomy with limited or without ischemia time
40. Application of the KEYNOTE-564 trial results to real life population: Which patients with advanced kidney cancer should receive adjuvant pembrolizumab
41. The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain
42. The learning curve of radical nephrectomy for kidney cancer: Implications for surgical training
43. Sustainable multidisciplinary team referral for non-metastatic renal cell carcinoma: A survival-based recommendation
44. Frailty status predicts worse postoperative outcomes and long-term oncologic outcomes in patients treated with partial nephrectomy
45. The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort
46. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma
47. Assessing the need for systematic biopsies in addition to targeted biopsies according to the volume of the index lesion diagnosed at mpmri. Results from a large multi-institutional database
48. Should we routinely recommend a central review of magnetic resonance imaging of the prostate in men with positive mp-MRI? Implication for targeted biopsies
49. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
50. The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.